Literature DB >> 12700355

The role of side-chain interactions in the early steps of aggregation: Molecular dynamics simulations of an amyloid-forming peptide from the yeast prion Sup35.

Jörg Gsponer1, Urs Haberthür, Amedeo Caflisch.   

Abstract

Understanding the early steps of aggregation at atomic detail might be crucial for the rational design of therapeutics preventing diseases associated with amyloid deposits. In this paper, aggregation of the heptapeptide GNNQQNY, from the N-terminal prion-determining domain of the yeast protein Sup35, was studied by 20 molecular dynamics runs for a total simulation time of 20 micros. The simulations generate in-register parallel packing of GNNQQNY beta-strands that is consistent with x-ray diffraction and Fourier transform infrared data. The statistically preferred aggregation pathway does not correspond to a purely downhill profile of the energy surface because of the presence of enthalpic barriers that originate from out-of-register interactions. The parallel beta-sheet arrangement is favored over the antiparallel because of side-chain contacts; in particular, stacking interactions of the tyrosine rings and hydrogen bonds between amide groups. No ordered aggregation was found in control simulations with the mutant sequence SQNGNQQRG in accord with experimental data and the strong sequence dependence of aggregation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12700355      PMCID: PMC154314          DOI: 10.1073/pnas.0835307100

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  28 in total

1.  Native topology or specific interactions: what is more important for protein folding?

Authors:  P Ferrara; A Caflisch
Journal:  J Mol Biol       Date:  2001-03-02       Impact factor: 5.469

2.  An amyloid-forming peptide from the yeast prion Sup35 reveals a dehydrated beta-sheet structure for amyloid.

Authors:  M Balbirnie; R Grothe; D S Eisenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-20       Impact factor: 11.205

Review 3.  Fast kinetics and mechanisms in protein folding.

Authors:  W A Eaton; V Muñoz; S J Hagen; G S Jas; L J Lapidus; E R Henry; J Hofrichter
Journal:  Annu Rev Biophys Biomol Struct       Date:  2000

4.  A possible role for pi-stacking in the self-assembly of amyloid fibrils.

Authors:  Ehud Gazit
Journal:  FASEB J       Date:  2002-01       Impact factor: 5.191

5.  Evaluation of a fast implicit solvent model for molecular dynamics simulations.

Authors:  Philippe Ferrara; Joannis Apostolakis; Amedeo Caflisch
Journal:  Proteins       Date:  2002-01-01

6.  Protein refolding versus aggregation: computer simulations on an intermediate-resolution protein model.

Authors:  A V Smith; C K Hall
Journal:  J Mol Biol       Date:  2001-09-07       Impact factor: 5.469

7.  Role of native topology investigated by multiple unfolding simulations of four SH3 domains.

Authors:  J Gsponer; A Caflisch
Journal:  J Mol Biol       Date:  2001-05-25       Impact factor: 5.469

8.  Analysis of the minimal amyloid-forming fragment of the islet amyloid polypeptide. An experimental support for the key role of the phenylalanine residue in amyloid formation.

Authors:  R Azriel; E Gazit
Journal:  J Biol Chem       Date:  2001-07-09       Impact factor: 5.157

9.  Analysis of protein aggregation kinetics.

Authors:  F Ferrone
Journal:  Methods Enzymol       Date:  1999       Impact factor: 1.600

10.  Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases.

Authors:  Monica Bucciantini; Elisa Giannoni; Fabrizio Chiti; Fabiana Baroni; Lucia Formigli; Jesús Zurdo; Niccolò Taddei; Giampietro Ramponi; Christopher M Dobson; Massimo Stefani
Journal:  Nature       Date:  2002-04-04       Impact factor: 49.962

View more
  73 in total

1.  The role of aromaticity, exposed surface, and dipole moment in determining protein aggregation rates.

Authors:  Gian Gaetano Tartaglia; Andrea Cavalli; Riccardo Pellarin; Amedeo Caflisch
Journal:  Protein Sci       Date:  2004-05-28       Impact factor: 6.725

2.  The stability and dynamics of the human calcitonin amyloid peptide DFNKF.

Authors:  Hui-Hsu Tsai; David Zanuy; Nurit Haspel; Kannan Gunasekaran; Buyong Ma; Chung-Jung Tsai; Ruth Nussinov
Journal:  Biophys J       Date:  2004-07       Impact factor: 4.033

3.  Self-assembly of the ionic peptide EAK16: the effect of charge distributions on self-assembly.

Authors:  S Jun; Y Hong; H Imamura; B-Y Ha; J Bechhoefer; P Chen
Journal:  Biophys J       Date:  2004-08       Impact factor: 4.033

4.  Oligomerization of amyloid Abeta16-22 peptides using hydrogen bonds and hydrophobicity forces.

Authors:  Giorgio Favrin; Anders Irbäck; Sandipan Mohanty
Journal:  Biophys J       Date:  2004-09-17       Impact factor: 4.033

5.  Sampling the self-assembly pathways of KFFE hexamers.

Authors:  Guanghong Wei; Normand Mousseau; Philippe Derreumaux
Journal:  Biophys J       Date:  2004-09-17       Impact factor: 4.033

6.  Formation of partially ordered oligomers of amyloidogenic hexapeptide (NFGAIL) in aqueous solution observed in molecular dynamics simulations.

Authors:  Chun Wu; Hongxing Lei; Yong Duan
Journal:  Biophys J       Date:  2004-08-23       Impact factor: 4.033

7.  Kinetic control of dimer structure formation in amyloid fibrillogenesis.

Authors:  Wonmuk Hwang; Shuguang Zhang; Roger D Kamm; Martin Karplus
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-23       Impact factor: 11.205

8.  Phase diagrams describing fibrillization by polyalanine peptides.

Authors:  Hung D Nguyen; Carol K Hall
Journal:  Biophys J       Date:  2004-10-01       Impact factor: 4.033

9.  Aqueous urea solution destabilizes Abeta(16-22) oligomers.

Authors:  D K Klimov; John E Straub; D Thirumalai
Journal:  Proc Natl Acad Sci U S A       Date:  2004-10-01       Impact factor: 11.205

10.  A variational model for oligomer-formation process of GNNQQNY peptide from yeast prion protein Sup35.

Authors:  Xianghong Qi; Liu Hong; Yang Zhang
Journal:  Biophys J       Date:  2012-02-07       Impact factor: 4.033

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.